Steps to Take Before Taking GLP-1 Medications
Step 1: Get a Baseline Liver Panel Before Your First Dose
Ideally, you’ll do your baseline panel in the days or weeks before your first dose of GLP-1 medication. The core liver markers to include are:
- ALT (alanine aminotransferase) — This is the most liver-specific enzyme. Elevated ALT is often the first sign of liver cell stress or fat accumulation.
- AST (aspartate aminotransferase) — AST is found in the liver and other tissues (like muscle). It’s useful alongside ALT to narrow down the source of any abnormality.
- ALP (alkaline phosphatase) — Measuring ALP is helpful for spotting bile duct or gallbladder issues, which matters since GLP-1s carry a small increased risk of gallstones.
- GGT (gamma-glutamyl transferase) — GGT is sensitive to bile duct problems and alcohol-related liver stress. It’s often used alongside ALP for clarification.
- Total and direct bilirubin — This marker tells you how well the liver is processing waste products. It’s useful for catching bile flow issues early.
- Albumin and total protein — These markers reflect the liver's synthetic function over time.
Step 2: Understand What "Normal" Looks Like for You
To measure and track biomarkers you have to know what’s considered “normal” and what’s normal for you. The general adult ranges for liver enzymes are:
| Marker |
Typical Reference Range* |
| ALT |
~7–56 U/L |
| AST |
~10–40 U/L |
| ALP |
~44–147 U/L |
| GGT |
~9–48 U/L |
| Total bilirubin |
~0.1–1.2 mg/dL |
A single mildly elevated value isn't automatically a red flag. Your labs can fluctuate with hydration, recent exercise, alcohol use and even the medications you're already taking. What matters more is the trend over time and whether multiple markers move together.
Step 3: Retest 4–12 Weeks After Starting
Most clinical monitoring approaches call for a follow-up liver panel roughly 4–12 weeks after your first dose, then periodically thereafter (usually every few months during dose titration, and at least annually once you're on a stable maintenance dose). Retesting sooner around the 4-week mark makes sense if you:
- Started with any liver enzymes near or above the top of the normal range
- Have a known fatty liver diagnosis
- Are on a higher starting dose or titrating quickly
- Notice symptoms like unusual fatigue, upper-right abdominal discomfort, dark urine or yellowing of the skin or eyes. These warrant prompt medical attention regardless of your testing schedule.
Step 4: Know What Improvement Looks Like
One of the more encouraging patterns seen with GLP-1 therapy is a decrease in ALT and AST over the first several months, often paralleling weight loss and improved insulin sensitivity. This is consistent with reduced liver fat. If your goal in starting a GLP-1 includes addressing fatty liver disease, declining enzyme levels alongside weight loss is generally a reassuring sign that the medication is doing what you hoped.
Step 5: Know What Warrants a Closer Look
With at-home liver tests you’re able to arrange lab work on your own, but that doesn’t mean you’re on your own to interpret the results. Contact your prescriber if you notice:
- Liver enzymes that are rising rather than falling or holding steady
- Any single enzyme significantly above the normal range (generally more than 2–3x the upper limit, though your provider will interpret this in context)
- New symptoms: persistent nausea beyond the typical adjustment period, right upper abdominal pain, unusual fatigue, dark urine, pale stools or yellowing of the skin/eyes
- A new gallstone diagnosis, since gallbladder issues are a known (if uncommon) consideration with rapid weight loss
None of this is meant to replace medical advice. It's meant to help you know what to bring up with your provider and when.